BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33135335)

  • 1. Differences in survival of prostate cancer Gleason 8-10 disease and the establishment of a new Gleason survival grading system.
    Zhou Y; Lin C; Hu Z; Yang C; Zhang R; Ding Y; Wang Z; Tao S; Qin Y
    Cancer Med; 2021 Jan; 10(1):87-97. PubMed ID: 33135335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
    Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
    Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
    Castro E; Goh C; Olmos D; Saunders E; Leongamornlert D; Tymrakiewicz M; Mahmud N; Dadaev T; Govindasami K; Guy M; Sawyer E; Wilkinson R; Ardern-Jones A; Ellis S; Frost D; Peock S; Evans DG; Tischkowitz M; Cole T; Davidson R; Eccles D; Brewer C; Douglas F; Porteous ME; Donaldson A; Dorkins H; Izatt L; Cook J; Hodgson S; Kennedy MJ; Side LE; Eason J; Murray A; Antoniou AC; Easton DF; Kote-Jarai Z; Eeles R
    J Clin Oncol; 2013 May; 31(14):1748-57. PubMed ID: 23569316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer.
    Sun GX; Shen PF; Zhang XM; Gong J; Gui HJ; Shu KP; Liu JD; Zhao J; Yang YJ; Chen XQ; Chen N; Zeng H
    Asian J Androl; 2017; 19(5):573-578. PubMed ID: 27569001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
    Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
    World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
    Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
    Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal Laser Ablation Versus Radical Prostatectomy for Localized Prostate Cancer: Survival Outcomes From a Matched Cohort.
    Zheng X; Jin K; Qiu S; Han X; Liao X; Yang L; Wei Q
    Clin Genitourin Cancer; 2019 Dec; 17(6):464-469.e3. PubMed ID: 31594734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single Positive Lymph Node Prostate Cancer Can Be Treated Surgically without Recurrence.
    Kim DK; Koo KC; Abdel Raheem A; Kim KH; Chung BH; Choi YD; Rha KH
    PLoS One; 2016; 11(3):e0152391. PubMed ID: 27031340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database.
    Liu YL; Wang DW; Yang ZC; Ma R; Li Z; Suo W; Zhao Z; Li ZW
    Breast Cancer Res Treat; 2019 Nov; 178(2):379-388. PubMed ID: 31414242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing effectiveness of radical prostatectomy versus external beam radiotherapy in patients with locally advanced prostate cancer: A population-based analysis.
    Zhou X; Jin K; Qiu S; Jin D; Liao X; Tu X; Zheng X; Li J; Yang L; Wei Q
    Medicine (Baltimore); 2020 Aug; 99(34):e21642. PubMed ID: 32846773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
    Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
    J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer.
    Lin CC; Gray PJ; Jemal A; Efstathiou JA
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25957435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Active Surveillance for Men With Intermediate Risk Prostate Cancer: A Population-Based Analysis.
    Chandrasekar T; Bowler N; Schneider A; Goldberg H; Mark JR; Trabulsi EJ; Lallas CD; Gomella LG
    Urology; 2021 Sep; 155():101-109. PubMed ID: 34186134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort.
    Gomez-Iturriaga A; Cabeza Á; Pastor J; Jove J; Casaña M; Caamaño AG; Mengual J; Henríquez I; Muñoz J; Hervás A; Segundo CG
    Clin Transl Oncol; 2016 Oct; 18(10):1026-33. PubMed ID: 26781470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.
    Worni M; Akushevich I; Gloor B; Scarborough J; Chino JP; Jacobs DO; Hahn SM; Clary BM; Pietrobon R; Shah A
    Ann Surg Oncol; 2012 Apr; 19(4):1316-23. PubMed ID: 22002799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of Gleason scores in metastatic prostate cancer.
    Rusthoven CG; Carlson JA; Waxweiler TV; Yeh N; Raben D; Flaig TW; Kavanagh BD
    Urol Oncol; 2014 Jul; 32(5):707-13. PubMed ID: 24629494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
    Xu Y; Huang T; Mao M; Zhai J; Chen J
    Laryngoscope; 2021 Apr; 131(4):E1130-E1138. PubMed ID: 32833262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
    Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
    Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.